Search results

Articles (5)

Journals (0)

1-5 of 5 results for ABT-263

Sort by:

Relevance

Select all

Sort by:

Relevance

Free access

Other

First published 2019-2

The ratio of Bcl-2/Bim as a predictor of cisplatin response provides a rational combination of ABT-263 with cisplatin or radiation in small cell lung cancer

Hong Li, Huogang Wang, Ke Deng [...]

Cancer Biomarkers

Retricted access

Research article

First published 2023-02

Navitoclax (ABT-263) Rejuvenates Human Skin by Eliminating Senescent Dermal Fibroblasts in a Mouse/Human Chimeric Model

Kento Takaya, Tatsuyuki Ishii, Toru Asou [...]

Rejuvenation Research

Retricted access

Research article

First published 2014-04

Multiplex Analysis of Anti-Apoptotic BCL2 Family and Caspase 3 Activation by Microbead Arrays

Lloyd T. Lam, Lisa Roberts-Rapp

ASSAY and Drug Development Technologies

Retricted access

Article commentary

First published 2024-03-19

A Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain

Miranda E. Orr

Journal of Alzheimer’s Disease

Retricted access

Review article

First published 2017-5

Venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid Malignancies

Amber C. King, Tim J. Peterson, Troy Z. Horvat [...]

Annals of Pharmacotherapy